Pancreatic Cancer Research

ResearcherZhejiang Provincial People's HospitalActive in the last 2 years

Tao Xia

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0005-3825-3235. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2023: 1 paper · 2024: none · 2025: none · 2026: 1 paper

Papers 2

  1. Extracellular Vesicle-Derived Adenosine as a Diagnostic Metabolic Biomarker for Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.4143/crt.2025.510↗
  2. Factors predicting recurrence after left‑sided pancreatectomy for pancreatic ductal adenocarcinoma. Co-author DOI 10.1186/s12957-023-03080-z↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yiping Mou · 2 shared papers, 2023–2026 · strength 0.49
  2. Shanying Gui · 1 shared paper, 2026 · strength 0.32
  3. Wenhui Ouyang · 1 shared paper, 2026 · strength 0.32
  4. Hezhi Fang · 1 shared paper, 2026 · strength 0.32
  5. Yuanyu Wang · 1 shared paper, 2023 · strength 0.17
  6. Yunyun Xu · 1 shared paper, 2023 · strength 0.17
  7. Peng Xu · 1 shared paper, 2023 · strength 0.17
  8. Yucheng Zhou · 1 shared paper, 2023 · strength 0.17
  9. Weiwei Jin · 1 shared paper, 2023 · strength 0.17

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.